Author: Adis International Limited
Publisher: Adis International
ISSN: 1176-3469
Source: Pharmaceutical & Diagnostic Innovation, Vol.3, Iss.8, 2005-01, pp. : 10-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
New Antiparkinsonian Agents Target Unmet Therapeutic Needs
Pharmaceutical & Diagnostic Innovation, Vol. 2, Iss. 3, 2004-06 ,pp. :
CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 10, Iss. 5, 2011-08 ,pp. :
By Lee Tak H
Clinical Medicine, Vol. 3, Iss. 4, 2003-07 ,pp. :
Managing the first episode of schizophrenia: the role of new therapies
European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. :